Claims Data Analysis of Tumor Necrosis Factor Inhibitor Treatment Dosing Among Patients with Rheumatoid Arthritis: A Systematic Review of Methods

BACKGROUND: With tumor necrosis factor inhibitors, changes of dosing, switching between drugs, insufficient adherence, and persistence are frequent in rheumatoid arthritis. Because this is often associated with decreased efficiency and increased costs, dosage analyses based on claims data are of inc...

Descripción completa

Detalles Bibliográficos
Autores principales: Krack, Gundula, Zeidler, Henning, Zeidler, Jan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2016
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5042945/
https://www.ncbi.nlm.nih.gov/pubmed/27747836
http://dx.doi.org/10.1007/s40801-016-0089-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5042945/
https://www.ncbi.nlm.nih.gov/pubmed/27747836
http://dx.doi.org/10.1007/s40801-016-0089-y

Ejemplares similares